Avrobio | Lucro Operacional

Operating Profit Alterar Data
Adcock Ingram Holdings ZAR 541.49M 52.55M 2023-06
Alnylam Pharmaceuticals USD -43435000 72.97M 2024-03
Ecofibre AUD -3356000 20.27M 2023-06
Gilead Sciences USD -191000000 1.8B 2024-03
Ionis Pharmaceuticals USD -149513000 170.19M 2024-03
Kangmei Pharma CNY -21752960 44.94M 2023-09
Knight Therapeutics CAD 2.29M 1.5M 2023-09
Laboratorios Farma EUR 85.28M 66.78M 2023-06
Malin Corporation EUR -2200000 800K 2023-06
Medical Developments International AUD -11427000 4.13M 2023-06
Neuren Pharmaceuticals AUD 48.83M 41.89M 2023-06
Organigram Holdings CAD -219637000 208.87M 2023-03
Pfizer USD 4.2B 10.75B 2024-03
Pharma Mar EUR -4330000 788K 2024-03
Probiotec AUD 8.03M 492.24K 2023-06
Qiagen NV USD 98.24M 12.37M 2024-03
Roche Holding CHF 9.76B 3.84B 2023-06
Sarepta Therapeutics USD 34.9M 83.25M 2024-03
Sartorius EUR 122.3M 2.3M 2024-03
Sino Biopharmaceutical CNY 3.75B 797.83M 2023-06
Takeda JPY 104.91B 154.26B 2023-12
Zz Pientze Pharmaceu 1.04B 113.61M 2023-09



Avrobio Lucro Operacional - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jun 2024.